King Pharmaceuticals to appeal decision on Altace patent
BRISTOL, Tenn. The U.S. Court of Appeals for the Federal Circuit will soon be receiving a motion to rehear King Pharmaceuticals case for a patent claim on its blood pressure medication, Altace.
The court had ruled in favor of Lupin’s application for a generic version of the drug, which is co-marketed by King and Sanofi-Aventis. This though was after a lower court had ruled in favor of King.
King’s patent was said to be invalid based on obviousness, which was used in the Supreme Court decision of KSR International v. Teleflex. The patent was set to expire in October 2008 of the drug, which made up sales of $163 million in the second quarter, but now the generic could be launched by the end of the year.
King though expects to file a new drug application for an Altace diuretic combination drug its been working on and has just gotten positive results from a phase III clinical trial.
GSK will supply over 30 million doses of flu vaccines to U.S. this season
PHILADELPHIA The influenza virus vaccines Fluarix and FluLaval from GlaxoSmithKline will have a combined total of 30 million to 35 million doses supplied to the U.S. markets for the 2007-08 influenza season.
The vaccines will be delivered in phased approach for the rest of September and all of October with completion occurring at the end of October. “Providing an ample and steadily growing supply of flu vaccine has been a priority for GlaxoSmithKline since entering the U.S. market in 2004,” said David Pernock, senior vice president of GSK. “Over the years, GSK has significantly increased its influenza vaccine manufacturing capacity, and we have taken steps to improve the way this product is distributed to those who need it.”
Last year, the company sent about 25 million doses of the drugs for flu season.
NACDS pledges to award at least $100,000 in scholarships
ALEXANDRIA, Va. The National Association of Chain Drug Stores Foundation is pledging to award at least $100,000 this year in scholarships, and has begun accepting applications.
Last year, 40 students were awarded a scholarship, an increase of three from 2005, and this year it looks like the foundation wants to add award the scholarship of $2,000 to at least 50 students. Also, some select recipients will receive named scholarships in the amount of $2,500, in addition to the $2,000 scholarship.
Applicants must be at least in their second year of pharmacy school, as well as have experience and the desire to work in a chain community pharmacy.
“The NACDS Foundation is continuously committed to advancing the pharmacy industry for the good of the public. An important part of our industry is its future, and that is what these students represent,” said Phil Schneider, NACDS Foundation president. The deadline for all applications is Oct. 19.